Vitiligo Therapy in Children: A Case for Considering Excimer Laser Treatment

Abstract

Get full access to this article

View all access options for this article.

References

Mehta NR , Shah KC , Theodore C. , Vyas VP , Patel AB Epidemiological study of vitiligo in Surat area, South Gujarat. Indian J Med Res. 1973;61:145-154.

Howitz J. , Brodthagen H. , Schwartz M. , Thomsen K. Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark . Arch Dermatol. 1977; 113:47-52.

Boisseau-Garsaud AM , Garsaud P. , Calès-Quist D. , Hélénon R. , Quénéhervé C. , Claire RC Epidemiology of vitiligo in the French West Indies (Isle of Martinique). Int J Dermatol. 2000;39:18-20.

Lerner AB Vitiligo. J Invest Dermatol. 1959;32:285-310.

Halder RM , Grimes PE , Cowan CA , Enterline JA , Chakrabarti SG , Kenney JA Jr. Childhood vitiligo. J Am Acad Dermatol. 1987 ;16:948-954.

Handa S. , Dogra S. Epidemiology of childhood vitiligo: a study of 625 patients from north India . Pediatr Dermatol. 2003;20:207-210.

Hu Z. , Liu JB , Ma SS , Yang S. , Zhang XJ Profile of childhood vitiligo in China: an analysis of 541 patients. Pediatr Dermatol. 2006;23:114-116.

Jaisankar TJ , Baruah MC , Garg BR Vitiligo in children. Int J Dermatol. 1992;31:621-623.

Kyriakis, KP , Palamaras I. , Tsele E. , Michailides C. , Terzoudi S. Case detection rates of vitiligo by gender and age. Int J Dermatol. 2009;48:329-330.

10.

Castanet J. , Ortonne JP Pathophysiology of vitiligo. Clin Dermatol. 1997;15:845-851.

11.

Gauthier Y. , Cario Andre M. , Taieb A.

A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?

Pigment Cell Res. 2003;16:322-332.

12.

van den Boorn JG , Konijnenberg D. , Dellemijn TA , et al. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol . 2009;129:2220-2232.

13.

Porter, J. , Beuf AH , Nordlund JJ , Lerner AB Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry. 1979;1:73-77.

14.

Sampogna, F. , Raskovic D. , Guerra L. , et al. Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol. 2008;159: 351-359.

15.

Mattoo SK , Handa S. , Kaur I. , Gupta N. , Malhotra R. Psychiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol. 2002;16: 573-578.

16.

Parsad, D. , Dogra S. , Kanwar A. Quality of life in patients with vitiligo. Health Qual Life Outcomes. 2003;1:58.

17.

Halder RM Childhood vitiligo. Clin Dermatol. 1997;15: 899-906.

18.

Thompson AR , Kent G. , Smith JA Living with vitiligo: dealing with difference . Br J Health Pyschol. 2002;7: 213-225.

19.

Linthorst Homan MW , de Korte J. , Grootenhuis MA , Bos JD , Sprangers MA , van der Veen JP Impact of childhood vitiligo on adult life . Br J Dermatol. 2008;159: 915-920.

20.

Gawkrodger DJ , Ormerod AD , Shaw L. , et al. Guideline for the diagnosis and management of vitiligo. Br J Dermatol. 2008;159:1051-1076.

21.

Lotti T. , Gori A. , Zanieri F. , Colucci R. , Moretti S. Vitiligo: new and emerging treatments. Dermatol Ther. 2008;21: 110-117.

22.

Fitzpatrick TB Soleil et peau. J Med Esthet . 1975;2:33-34.

23.

Taneja A. Treatment of vitiligo. J Dermatol Treat. 2002 ; 13:19-25.

24.

Novak Z. , Berces A. , Ronto G. , Pallinger E. , Dobozy A. , Kemeny L. Efficacy of different UV-emitting light sources in the induction of T-cell apoptosis. Photochem Photobiol. 2004;79:434-439.

25.

Hong SB , Park HH , Lee MH Short-term effects of 308-nm xenon-chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: ctudy. J Korean Med Sci. 2005;20:273-278.

26.

Casacci M. , Thomas P. , Pacifico A. , Bonnevalle A. , Paro Vidolin A. , Leone G. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo: a multicentre controlled study . J Eur Acad Dermatol Venereol. 2007;21:956-963.

27.

Baltas E. , Csoma Z. , Ignacz F. , Dobozy A. , Kemeny L. Treatment of vitiligo with the 308-nm xenon chloride excimer laser. Arch Dermatol. 2002;138:1619-1620.

28.

Spencer JM , Nossa R. , Ajmeri J. Treatment of vitiligo with the 308-nm excimer laser: a pilot study. J Am Acad Dermatol. 2002;46:727-731.

29.

Hadi SM , Spencer JM , Lebwohl M. The use of the 308-nm excimer laser for the treatment of vitiligo. Dermatol Surg. 2004;30:983-986.

30.

Sassi F. , Cazzaniga S. , Tessari G. et al. Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck. Br J Dermatol. 2008;159: 1186-1191.

31.

Hofer A. , Hassan AS , Legat FJ , Kerl H. , Wolf P. The efficacy of excimer laser (308 nm) for vitiligo at different body sites . J Eur Acad Dermatol Venereol. 2006;20: 558-564.

32.

Esposito M. , Soda R. , Costanzo A. , Chimenti S. Treatment of vitiligo with the 308 nm excimer laser. Clin Exp Dermatol. 2004;29:133-137.

33.

Greve B. , Raulin C. , Fischer E. Excimer laser treatment of vitiligo-critical retrospective assessment of own results and literature overview [in German]. J Dtsch Dermatol Ges. 2006;4:32-40.

34.

Taneja A. , Trehan M. , Taylor CR 308-nm excimer laser for the treatment of localized vitiligo. Int J Dermatol. 2003;42:658-662.

35.

Ostovari N. , Passerson T. , Zakaria W. Treatment of vitiligo by 308-nm excimer laser: an evaluation of variables affecting treatment response. Lasers Surg Med. 2004;35: 152-156.

36.

Passeron T. , Ostovari N. , Zakaria W. , et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch Dermatol. 2004;140: 1065-1069.

37.

Kawalek AZ , Spencer JM , Phelps RG Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol Surg. 2004;30:130-135.

38.

Choi KH , Park JH , Ro YS Treatment of vitiligo with 308-nm xenon-chloride excimer laser: therapeutic efficacy of different initial doses according to treatment areas. J Dermatol. 2004;31:284-292.

39.

Hui-Lan Y. , Xiao-Yan H. , Jian-Yong F. , Zong-Rong L. Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo. Pediatr Dermatol. 2009;26:354-355.

40.

Hofer A. , Hassan AS , Legat FJ , Kerl H. , Wolf P. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients . Br J Dermatol. 2005;152:981-985.

41.

Shen Z. , Gao TW , Chen L. , et al. Optimal frequency of treatment with the 308-nm excimer laser for vitiligo on the face and neck. Photomed Laser Surg. 2007;25: 418-427.

42.

Cui J. , Shen LY , Wang GC Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol. 1991;97: 410-416.

43.

Goldinger SM , Dummer R. , Schmid P. , Burg G. , Seifert P. , Läuchli S. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo. J Eur Acad Dermatol Venereol. 2007;21:504-508.

44.

Man I. , Crombie IK , Dawe RS , Ibbotson SH , Ferguson J. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data. Br J Dermatol. 2005; 152:755-757.

45.

Weischer M. , Blum A. , Eberhard F. , Röcken M. , Berneburg M. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study. Acta Derm Venereol. 2004;84:370-374.